跳至主要内容
临床试验/ACTRN12615000923561
ACTRN12615000923561已完成4 期

Evaluation of the probiotic Lactobacillus Fermentum CECT5716 for the prevention of mastitis in breastfeeding women: a randomised controlled trial

Perinatal Research Group, Kolling Institute, University of Sydney0 个研究点目标入组 600 人开始时间: 2015年9月4日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Pregnant women at least 18 years of age at 37 weeks gestation or later with a singleton pregnancy will be invited to participate in the trial. They will currently not be taking commercial probiotics containing lactobacillus fermentum; and will own a smartphone. Their intention at the time of consent will be to breastfeed their baby.

排除标准

  • Women with a history of Raynaud syndrome will not be eligible to participate in the trial. Any delivery/breast complication rendering the infant unable to breastfeed will be excluded. Women unable to speak/understand English will not be consented.

研究者

发起方
Perinatal Research Group, Kolling Institute, University of Sydney

相似试验